BeauSaki Bird's Nest Peptide Efficacy

NCT07723508 | Completed

• 1 other identifier: TMSHIRB25-104-B
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are: Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks? Is the edible bird's nest peptide product well tolerated by participants during the study period? Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions. Participants will:

• Take one capsule daily for 8 weeks.
• Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments.
• Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment.
• Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8.
• Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.

Conditions

Facial Skin Condition

Keywords

Skin Hydration; Skin Elasticity; Skin Brightness; Transepidermal Water Loss; Wrinkles; Skin Texture

Outcome Measures

Primary Outcomes (3)

• Facial Skin Analysis Parameters

  VISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin spots, wrinkles, texture, pores, UV spots, brown Spots, red areas, porphyrins. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

  Baseline, week 4, and week 8

• Skin Moisture

  Skin moisture meter (VapoMeter) was utilized to measure skin moisture. Units: g/m²h Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

  Baseline, week 4, and week 8

• Skin elasticity

  Skin elastometer (Soft Plus) was utilized to measure skin elasticity. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

  Baseline, week 4, and week 8

Study Arms (2)

BeauSaki Edible Bird's Nest Peptide Group

EXPERIMENTAL

Participants in this group will take one capsule of BeauSaki Edible Bird's Nest Peptide Product daily for 8 weeks.

Dietary Supplement: BeauSaki Edible Bird's Nest Peptide Product

Placebo Group

PLACEBO COMPARATOR

Participants in this group will take one placebo capsule without edible bird's nest daily for 8 weeks.

Dietary Supplement: Placebo Capsule (matched dosing schedule)

Interventions

BeauSaki Edible Bird's Nest Peptide Product DIETARY_SUPPLEMENT

Participants will take one capsule daily for 8 weeks.

BeauSaki Edible Bird's Nest Peptide Group

Placebo Capsule (matched dosing schedule) DIETARY_SUPPLEMENT

Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.

Placebo Group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants aged over 18 years.

You may not qualify if:

• Individuals who are unwilling to participate voluntarily.
• Individuals diagnosed by a physician with skin disease, liver cirrhosis, or chronic renal failure.
• Individuals with known allergies to cosmetics, drugs, or foods.
• Pregnant or breastfeeding individuals.
• Individuals taking medications for chronic diseases.
• Students taught by the principal investigator.
• Individuals unwilling to allow their study-related photographs to be disclosed. Vegetarians.

Sponsors & Collaborators

• Chia Nan University of Pharmacy ＆ Science: lead

Study Sites (1)

Chia Nan University of Pharmacy ＆ Science

Tainan, Taiwan, 71710, Taiwan

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 9, 2026
• First Posted: July 23, 2026
• Study Start: October 1, 2025
• Primary Completion: January 31, 2026
• Study Completion: March 31, 2026
• Last Updated: July 23, 2026

Record last verified: 2026-07

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)